- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Alembic Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
| Financial Year | |||||
|---|---|---|---|---|---|
1,702.24 | 1,664.72 | 1,563.83 | 1,520.58 | 1,633.46 | |
| Other Income Qtr Cr | 9.50 | 16.74 | 2.10 | 3.60 | 2.89 |
| Operating Revenues Qtr | 1,692.74 | 1,647.98 | 1,561.73 | 1,516.98 | 1,630.57 |
*All values are in Cr. | |||||
1,432.52 | 1,408.71 | 1,324.90 | 1,256.92 | 1,364.21 | |
260.22 | 239.27 | 236.83 | 260.06 | 266.36 | |
269.72 | 268.88 | 238.93 | 263.66 | 269.25 | |
70.04 | 70.51 | 69.04 | 69.48 | 69.45 | |
138.42 | 153.40 | 134.71 | 178.21 | 180.45 | |
7.01 | 7.79 | 6.85 | 9.07 | 9.18 | |
Open Demat Account
Open Demat Account